View in EDS

Reprogramming CXCL10-mediated NK cell trafficking to enhance immunotherapy in osteosarcoma.

Saved in:
Bibliographic Details
Title: Reprogramming CXCL10-mediated NK cell trafficking to enhance immunotherapy in osteosarcoma.
Authors: Jayne WP; DO & MS Programs in Interdisciplinary Studies at Touro College of Osteopathic Medicine, Middletown, NY, USA., Freilich ME; DO & MS Programs in Interdisciplinary Studies at Touro College of Osteopathic Medicine, Middletown, NY, USA., Solanki R; Department of Basic Biomedical Sciences, Touro College of Osteopathic Medicine, Middletown, NY, USA., Challagundla KB; Department of Basic Biomedical Sciences, Touro College of Osteopathic Medicine, Middletown, NY, USA.
Source: Molecular therapy. Oncology [Mol Ther Oncol] 2026 Mar 11; Vol. 34 (1), pp. 201169. Date of Electronic Publication: 2026 Mar 11 (Print Publication: 2026).
Publication Type: News
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918752083706676 Publication Model: eCollection Cited Medium: Print ISSN: 2950-3299 (Print) Linking ISSN: 29503299 NLM ISO Abbreviation: Mol Ther Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41853565
AccessLevel: 2
PubType: Periodical
PubTypeId: serialPeriodical
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Reprogramming CXCL10-mediated NK cell trafficking to enhance immunotherapy in osteosarcoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jayne+WP%22">Jayne WP</searchLink>; DO & MS Programs in Interdisciplinary Studies at Touro College of Osteopathic Medicine, Middletown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Freilich+ME%22">Freilich ME</searchLink>; DO & MS Programs in Interdisciplinary Studies at Touro College of Osteopathic Medicine, Middletown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Solanki+R%22">Solanki R</searchLink>; Department of Basic Biomedical Sciences, Touro College of Osteopathic Medicine, Middletown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Challagundla+KB%22">Challagundla KB</searchLink>; Department of Basic Biomedical Sciences, Touro College of Osteopathic Medicine, Middletown, NY, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918752083706676%22">Molecular therapy. Oncology</searchLink> [Mol Ther Oncol] 2026 Mar 11; Vol. 34 (1), pp. 201169. <i>Date of Electronic Publication: </i>2026 Mar 11 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: News
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9918752083706676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2950-3299 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2229503299%22">29503299 </searchLink><i>NLM ISO Abbreviation: </i>Mol Ther Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41853565
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.omton.2026.201169
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 201169
    Titles:
      – TitleFull: Reprogramming CXCL10-mediated NK cell trafficking to enhance immunotherapy in osteosarcoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jayne WP
      – PersonEntity:
          Name:
            NameFull: Freilich ME
      – PersonEntity:
          Name:
            NameFull: Solanki R
      – PersonEntity:
          Name:
            NameFull: Challagundla KB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 11
              M: 03
              Text: 2026 Mar 11
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2950-3299
          Numbering:
            – Type: volume
              Value: 34
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Molecular therapy. Oncology
              Type: main
ResultId 1